Publicações

Design of a Double-Blind, Placebo- and Active-Controlled, Phase-Iii Trial in Patients with Parkinson's Disease and End-Of-Dose Motor Fluctuations: Opicapone Superiority Vs. Placebo and Non-Inferiority Vs. Entacapone

AuthID
P-002-5WC

Author(s)

Ferreira, J

Rocha, JF

Santos, A

Lopes, N

Nunes, T

Soares da Silva, P

Tipo de Documento

Abstract

Year published

2012

Publicado

in EUROPEAN JOURNAL OF NEUROLOGY, ISSN: 1351-5101

Volume: 19, Páginas: 695-695 (1)

Conference

16Th Congress of the European-Federation-Of-Neurological-Societies (Efns), Date: SEP 08-11, 2012, Location: Stockholm, SWEDEN, Patrocinadores: European Federat Neurol Soc (EFNS)

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000309359705017

Source Identifiers

ISSN: 1351-5101

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Design of a Double-Blind, Placebo- and Active-Controlled, Phase-Iii Trial in Patients with Parkinson's Disease and End-Of-Dose Motor Fluctuations: Opicapone Superiority Vs. Placebo and Non-Inferiority Vs. Entacapone

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Design of a Double-Blind, Placebo- and Active-Controlled, Phase-Iii Trial in Patients with Parkinson's Disease and End-Of-Dose Motor Fluctuations: Opicapone Superiority Vs. Placebo and Non-Inferiority Vs. Entacapone

Links Úteis

Ajuda